Biochemical Modulation by 5-Fluorouracil and 1-Folinic Acid of Tumor Uptake of Intra-Arterial 5-[¹²³I]Iodo-2'-Deoxyuridine in Patients with Liver Metastases from Colorectal Cancer

References

• Mariani G., Cei A., Giuliani L., et al. Tumor targeting potential and metabolism of 5-[125I]iodo-2'-deoxyuridine injected intra-tumorally in patients with gastrointestinal or breast cancers (abstract). J Nucl Biol Med 1992; 36: 154–7
   Google Scholar
• Mariani G., Cei A., Collecchi P., et al. Tumor targeting in vivo and metabolic fate of 5 [iodine-125]iodo-2'-deoxyuridine following intratumoral injection in patients with colorectal cancer. J Nucl Med 1993; 34: 1175–83
   PubMed Web of Science ®Google Scholar
• Mariani G., Collecchi P., Giuliani L., et al. Tumor targeting potential and metabolism of 5-[125I]iodo-2'-deoxyuridine injected intratumorally in patients with breast cancer. Ann NY Acad Sci 1993; 698: 204–11
   PubMed Web of Science ®Google Scholar
• Mariani G., Collecchi P., Baldassarri S., et al. Tumor uptake and mitotic activity pattern of 5-[125I]iodo-2'-deoxyuridine after intravesical infusion in patients with bladder cancer. J Nucl Med 1996; 37((Suppl))16S–19S
   PubMedGoogle Scholar
• Kassis Al, Adelstein S. J., Mariani G. Radiolabeled nucleoside analogs in cancer diagnosis and therapy. Q J Nucl Med 1997; 40: 301–19
   Google Scholar
• Szybalski W. X-ray sensitization by halopyrimidines. Cancer Chemother Rep 1974; 58: 539–57
   PubMedGoogle Scholar
• Philip P. A., Bagshawe K. D., Searle F., et al. In vivo uptake of 131I-5-iodo-2-deoxyuridine by malignant tumours in man. Br J Cancer 1991; 63: 134–5
   PubMedGoogle Scholar
• Mariani G., Di Sacco S., Matteucci F., et al. Tumor targeting by intra-arterial infusion of 5-[I-123]iodo-2'-deoxyuridine in patients with liver metastases from colon cancer (abstract). Eur J Nucl Med 1993; 20: 886
   Google Scholar
• Mariani G., Di Sacco S., Volterrani D., et al. Infusion of 5-[I-123]iodo-2'-deoxyuridine into the hepatic artery of patients with liver metastases from colorectal cancer (abstract). J Nucl Med 1994; 35: 144
   Google Scholar
• Mariani G., Di Sacco S., Volterrani D., et al. Tumor targeting by intra-arterial infusion of 5-[123I]iodo-2'-deoxyuridine in patients with liver metastases from colorectal cancer. J Nucl Med 1996; 37((Suppl))22S–25S
   PubMedGoogle Scholar
• Macapinlac H. A., Kemeny N., Daghighian F., et al. Pilot clinical trial of 5-[125I]Iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver. J Nucl Med 1996; 37((Suppl))25S–29S
   Google Scholar
• Ullman B., Lee M., Martin DW, Jr, Santi D. V. Cytotoxicity of 5-fluoro-2'-deoxy uridine: requirement for reduced folate cofactors and antagonism by methotrexate. Proc Natl Acad Sci USA 1978; 75: 980–3
   PubMed Web of Science ®Google Scholar
• Suzuki Y., Kobayashi S., Yasuda S. Application of single-photon emission computed tomography (SPECT) with 99mTc-MAA in evaluation of perfusion patterns during hepatic infusion chemotherapy. Ann Nucl Med 1991; 5: 123–6
   PubMedGoogle Scholar
• Baranowska-Kortylewicz J., Kinsey B. M., Layne W. W., Kassis A. I. Radioiodo-demercuration: a simple synthesis of 5-[123/125/127I]iodo-2'-deoxyuridine. Appl Radiat Isot 1988; 39: 335–41
   Web of Science ®Google Scholar
• Baranowska-Kortylewicz J., Helseth L. D., Lai J., Schneiderman M. H., Schneiderman G. S., Dalrymple G. V. Radiolabeling kit/generator for 5-radiohalogenated uridines. J Labelled Compd Radiopharm 1994; 34: 513–21
   Web of Science ®Google Scholar
• Foulon C. F., Zhang Y. Z., Adelstein S. J., Kassis A. I. Instantaneous preparation of radiolabeled 5-iodo-2'-deoxyuridine. Appl Radiat Isot 1995; 46: 1039–46
   PubMed Web of Science ®Google Scholar
• Piedbois P., Buyse M., Rustum Y., et al. (The Advanced Colorectal Cancer Meta-Analysis Project). Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 1992; 10: 896–903
   PubMed Web of Science ®Google Scholar
• Kaplan W. D., Ensminger W. D., Come S. E., et al. Radionuclide angiography to predict patient response to hepatic artery chemotherapy. Cancer Treat Rep 1980; 64: 1217–22
   PubMedGoogle Scholar